American Research & Management Company’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $81K | Hold |
460
| – | – | 0.02% | 163 |
|
|
2022
Q2 | $94K | Hold |
460
| – | – | 0.02% | 163 |
|
|
2022
Q1 | $109K | Hold |
460
| – | – | 0.02% | 162 |
|
|
2021
Q4 | $105K | Hold |
460
| – | – | 0.02% | 165 |
|
|
2021
Q3 | $89K | Hold |
460
| – | – | 0.02% | 172 |
|
|
2021
Q2 | $98K | Hold |
460
| – | – | 0.02% | 176 |
|
|
2021
Q1 | $94K | Hold |
460
| – | – | 0.02% | 165 |
|
|
2020
Q4 | $84K | Hold |
460
| – | – | 0.02% | 172 |
|
|
2020
Q3 | $77K | Hold |
460
| – | – | 0.02% | 163 |
|
|
2020
Q2 | $75K | Hold |
460
| – | – | 0.02% | 162 |
|
|
2020
Q1 | $80K | Hold |
460
| – | – | 0.03% | 149 |
|
|
2019
Q4 | $92K | Hold |
460
| – | – | 0.03% | 158 |
|
|
2019
Q3 | $97K | Hold |
460
| – | – | 0.03% | 158 |
|
|
2019
Q2 | $89K | Hold |
460
| – | – | 0.03% | 170 |
|
|
2019
Q1 | $76K | Hold |
460
| – | – | 0.02% | 187 |
|
|
2018
Q4 | $87K | Hold |
460
| – | – | 0.03% | 151 |
|
|
2018
Q3 | $78K | Hold |
460
| – | – | 0.02% | 169 |
|
|
2018
Q2 | $75K | Sell |
460
-50
| -10% | -$8.17K | 0.03% | 155 |
|
|
2018
Q1 | $82K | Hold |
510
| – | – | 0.03% | 156 |
|
|
2017
Q4 | $74K | Hold |
510
| – | – | 0.02% | 165 |
|
|
2017
Q3 | $69K | Hold |
510
| – | – | 0.02% | 154 |
|
|
2017
Q2 | $64K | Hold |
510
| – | – | 0.02% | 153 |
|
|
2017
Q1 | $61K | Sell |
510
-325
| -39% | -$39.1K | 0.02% | 148 |
|
|
2016
Q4 | $96K | Hold |
835
| – | – | 0.03% | 143 |
|
|
2016
Q3 | $87K | Hold |
835
| – | – | 0.03% | 146 |
|
|
2016
Q2 | $81K | Hold |
835
| – | – | 0.03% | 139 |
|
|
2016
Q1 | $80K | Hold |
835
| – | – | 0.03% | 137 |
|
|
2015
Q4 | $76K | Sell |
835
-100
| -11% | -$9.41K | 0.03% | 142 |
|
|
2015
Q3 | $87K | Buy |
935
+100
| +12% | +$9.51K | 0.04% | 137 |
|
|
2015
Q2 | $78K | Hold |
835
| – | – | 0.03% | 147 |
|
|
2015
Q1 | $79K | Hold |
835
| – | – | 0.03% | 147 |
|
|
2014
Q4 | $74K | Sell |
835
-100
| -11% | -$8.47K | 0.03% | 150 |
|
|
2014
Q3 | $75K | Sell |
935
-50
| -5% | -$3.77K | 0.03% | 151 |
|
|
2014
Q2 | $70K | Hold |
985
| – | – | 0.02% | 155 |
|
|
2014
Q1 | $73K | Sell |
985
-125
| -11% | -$9.43K | 0.03% | 151 |
|
|
2013
Q4 | $87K | Sell |
1,110
-125
| -10% | -$9.79K | 0.03% | 139 |
|
|
2013
Q3 | $91K | Sell |
1,235
-100
| -7% | -$7.37K | 0.04% | 138 |
|
|
2013
Q2 | $101K | Buy |
+1,335
| New | +$87.6K | 0.04% | 132 |
|
Other funds holding CME
American Research & Management Company's CME Position: Q3 2022 in Review
American Research & Management Company held its CME Group (CME) position steady in Q3 2022 at 460 shares worth $81K. The position accounts for 0.02% of the portfolio, ranked #163.
American Research & Management Company first reported a position in CME in Q2 2013 and has held it in 38 quarters since. The position peaked at $109K in Q1 2022. 1,146 funds tracked by Wall St. Rank hold CME as of Q3 2022.
- American Research & Management Company held 460 shares of CME Group worth $81K as of Q3 2022.
- American Research & Management Company left its CME Group share count unchanged in Q3 2022.
- CME Group made up 0.02% of American Research & Management Company's portfolio in Q3 2022, its #163 holding.
- American Research & Management Company first reported a position in CME Group in Q2 2013 and has held it in 38 quarters since.
- American Research & Management Company's CME Group position peaked at $109K in Q1 2022.
- 1,146 funds tracked by Wall St. Rank held CME Group as of Q3 2022.
Based on American Research & Management Company's 13F filing for Q3 2022, filed 7 Oct 2022.